Magnolia Medical Technologies Files for Permanent Injunction Against Infringing Kurin Lock Products – QNT Press Release


SEATTLE, Sept 13, 2022 /PRNewswire/ — Magnolia Medical Technologies, Inc. (“Magnolia Medical”), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) family of products, today announced it filed a motion for permanent injunction in the US District Court for the District of Delaware on September 9, 2022that would prohibit Kurin, Inc. (“Kurin”) from the continued sale of the infringing Kurin Lock products.

The filing follows two recent jury verdicts in Magnolia Medical’s favor. The first verdict found that Kurin infringed Magnolia Medical’s US Patent No. 10,039,483, using the company’s patented innovative technology without permission. The second verdict rejected Kurin’s attempts to invalidate the asserted claims and awarded significant damages for the sale of the infringing Kurin Lock product, including a 17.7% royalty.

“We have invested over a decade in pioneering and proving the…

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center